Search
for
Sort by
Community 121–150 of 333
- Stop Using Salicylic acid on your face if using minoxidil for beard growth
- for those who had high levels of testo and estradiol after start fin/dut: did it comeback to baseline or normal levels?
- Next month marks 2 years on Dutasteride. When does it start working?
- Stopped topical Minox and Fin for 2 years, started again and gained my old status back
- Why are there no FDA approved NSAA's yet?
- 5ar Type I in the frontal hair follicles - Dutasteride
- Breaking hair loss news! GT20029 is a resounding success!
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- bro where tf is GT20029, Q1 2024 is over already
- Dutasteride Vs. Testosterone, who wins?
- How to get rid of Estradiol Problems
- Can I Use Topical Azelaic Acid & Oral Finasteride At The Same Time?
- How to know if shedding is from tren or minoxidil?
- 6 months into Dutasteride and my hair is way worse than before
- Is there a consensus on RU these days? Pyril turned out to be a bust right?
- Is this broscience? From More Plates, More Dates
- Any other treatments to still be hopeful for?
- 0.5mg Dutasteride promotes more “regrowth” than 5mg oral Minoxidil
- Testosterone in Reference Range Doesn't Cause Hair Loss
- Any news on potential hair loss treatments?
- What are the upcoming or promising future developments in hair loss?
- If RU58841 is such an effective anti androgen
- I am horny as hell due to fin.
- Pyrilutamide phase III clinical trial results released
- Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.
- I really hate how current hair loss treatment only rely on DHT blockers
- Switched from finasteride to dutasteride - 2 month update
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- Testosterone and hair loss seeming irrelevance